Figure 3.
Kaplan–Meier analysis of 6- and 12-month effectiveness endpoint, time to first documented symptomatic effectiveness failure (per-protocol population, N = 85). AF, atrial fibrillation; AFL, atrial flutter; AT, atrial tachycardia.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.